Innovation Pharmaceuticals Inc. (11) | Business Finance (9)
Browse by Subcategory
Recent Contracts
-
Series A Preferred Share Purchase Agreement, dated June 9, 2022, by and among Squalus Med Ltd. and Innovation Pharmaceuticals Inc
(Filed With SEC on June 15, 2022)
-
Form of Warrant
(Filed With SEC on December 10, 2020)
-
Securities Purchase Agreement, dated December 9, 2020, between the Company and the investor party thereto
(Filed With SEC on December 10, 2020)
-
Registration Rights Agreement, dated July 31, 2020, between Innovation Pharmaceuticals Inc. and Aspire Capital Fund, LLC
(Filed With SEC on August 4, 2020)
-
Common Stock Purchase Agreement, dated July 31, 2020, between Innovation Pharmaceuticals Inc. and Aspire Capital Fund, LLC
(Filed With SEC on August 4, 2020)
-
Form of Warrant Amendment Agreement, dated December 26, 2019, between the Company and each investor party thereto
(Filed With SEC on December 26, 2019)
-
Description of Class A common stock
(Filed With SEC on September 30, 2019)
-
Form of Series 4 Warrant
(Filed With SEC on May 10, 2019)
-
Form of Warrant Restructuring and Additional Issuance Agreement, dated May 9, 2019, between the Company and the investors party thereto
(Filed With SEC on May 10, 2019)